Free-cash-flow proxy decreased 80.6%
Free-cash-flow proxy changed -80.6% from the comparable as-filed period.
$9.0B→$1.7B3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →META financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow increased 24.7%
Operating cash flow changed +24.7% from the comparable as-filed period.
$25.6B→$31.9B3 prior comparisons
Operating margin moved 1214 bp lower
Operating margin changed -1214 basis points from the comparable as-filed period.
43.02%→30.88%2 prior comparisons
Revenue increased 28.0%
Revenue changed +28.0% from the comparable as-filed period.
$47.5B→$60.8B2 prior comparisons
Research & development increased 67.3%
Research & development changed +67.3% from the comparable as-filed period.
$12.9B→$21.7B2 prior comparisons
Current ratio increased 12.8%
Current ratio changed +12.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
1.97→2.234 prior comparisons
Capex / revenue moved 1473 bp higher
Capex / revenue changed +1473 basis points from the comparable as-filed period.
34.81%→49.53%2 prior comparisons
Capital expenditure increased 82.1%
Capital expenditure changed +82.1% from the comparable as-filed period.
$16.5B→$30.1B3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.